What does the evidence say about Uridine Cognition Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Uridine Cognition Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Six representative small-molecule constituents were isolated and structurally characterized from the edible mushroom Tremella fuciformis : cis -oleic acid ( 1 ), 1-oleoylglycerol ( 2 ), cerevisterol ( 3 ), a cerebroside ( 4 ), trans -homoaconitic acid ( 5 ), and uridine ( 6 ). [Wang F (2026); evidence level 4] - Compound 5 , a tricarboxylic acid derivative, is reported for the first time as abundantly accumulated in this fungus. [Wang F (2026); evidence level 4] - Specifically,depletion andenrichment are associated with cognitive impairment, mediated by tetradecyldiethanolamine and index of diffusivity along the perivascular spaces, providing preliminary insights into plausible microbiota‐metabolites‐glymphatic function‐cognition associations in WMH. [Xu Xiaotao (2026); evidence level 4] -   Demographicand clinical data, including age, sex, years of education, and vascular risk factors, were collected through structured interviews and clinical assessments. [Xu Xiaotao (2026); evidence level 4] - These analyses were adjusted for potential confounders, including age, sex, education, and vascular risk factors. [Xu Xiaotao (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.